Skip to main content
OpenTrials
Completed

NCT Number: NCT02152189

Screening for Fabry Disease in a Pediatric Population at Risk

The purpose of this study is to assess the frequency of Fabry disease in children with chronic abdominal pain or chronic pain in the extremities

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age below 18 years
  • One of the following criteria:
  • Diagnosis or suspicion of a rheumatological disorder with recurrent complaints for more than 6 months
  • Chronic, recurrent abdominal pain for more than 6 months
  • Planned blood sample for routine diagnostics
  • Written informed consent

Exclusion criteria

  • Patient and/or the patient's parent(s) or legal guardian(s) are unable to understand the nature, scope, and possible consequences of the screening.

Treatment and study plan

Screening for Fabry disease

Other

Primary outcomes

  1. Prevalence of Fabry disease

    Time frame: day 1

Secondary outcomes

  1. Prevalence of Fabry disease in predefined sub-populations

    Time frame: day 1

Sponsors and collaborators

Lead sponsor

University Hospital Heidelberg

Other

Registry information

Important dates

Study start
2014
Primary completion
2017
Study completion
2017
First posted
Jun 2, 2014
Registry last updated
Dec 13, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.